Paraspinal Block in Nonspecific Low Back Pain

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the effects of a treatment involving the application of lidocaine injected on the low back area for pain control. The study will compare this form of treatment with other options such as physical exercises or pain killer medication, different measurements are going to be used to quantify the response to each of these treatments.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Marta Imamura
• Collaborator: Spaulding Rehabilitation Hospital
• Treatments: Lidocaine

Criteria

Inclusion criteria:

• Age between 20 to 60 years;

• Clinical symptoms of vertebral pain that is unresponsive to symptomatic treatment with anti-inflammatory drugs for 3 months;

• Moderate to severe pain: visual analog scale (VAS) > 4;

• Diagnosis of chronic nonspecific low back pain;

• MiniMental test (MEEM) between 24 and 30;

• Availability to comply with the visits;

• Agree with signing the Informed Consent Form

Exclusion criteria:

• Severe psychiatric disease that requires psychiatric care;

• Neurological disorders (lumbosciatic pain);

• Concurrent fibromyalgia, per the 1990 diagnostic criteria of the American Academy of Rheumatology

• Concurrent rheumatic disease

• History of allergy to lidocaine (used for paraspinal blocks)

• Labor problems

• History of surgery on the lumbar spine

• No availability to visit the clinic for treatment and evaluations.